{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T19:31:16Z","timestamp":1771270276903,"version":"3.50.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001747","name":"Hong Kong Baptist University","doi-asserted-by":"publisher","award":["FRG2\/15-16\/052"],"award-info":[{"award-number":["FRG2\/15-16\/052"]}],"id":[{"id":"10.13039\/501100001747","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Pompe disease (PD) is a rare inherited disorder caused by the deficiency of acid-\u03b1 glucosidase, which leads to the impairment of organ and tissue functions and causes disabilities. As the first national survey on patients with late-onset PD (LOPD) in China, this study investigated the quality of life (QOL) of adult patients with LOPD in China and explored its contributors.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Data were derived from a nation-based, cross-sectional, self-response survey on rare diseases (RDs) in early 2018. Answers from 68 adult Chinese patients with LOPD were used for data analysis. QOL was measured using the World Health Organization Quality of Life: Brief Version. Covariates included age, gender, education, employment, reliance on assistive devices, medication history, social support, and disease economic burden. Data were analyzed using linear regression in R.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>For adult patients with LOPD, the average scores and standard deviations (SD) of the four dimensions of QOL were physical health\u2009=\u200933.77 (SD\u2009=\u200918.28), psychological health\u2009=\u200943.81 (SD\u2009=\u200921.70), environmental health\u2009=\u200939.43 (SD\u2009=\u200916.93), and social relationship\u2009=\u200946.20 (SD\u2009=\u200919.76); the scoring for each dimension was evaluated on a scale of 0 to 100. At the significance level of <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05, with increasing age, the patients experienced a significant decrease in physical health QOL (\u03b2\u2009=\u2009\u2212\u20090.75) and environmental health QOL (\u03b2\u2009=\u2009\u2212\u20090.79). Those who relied heavily on assistive devices had lower perceived physical health (\u03b2\u2009=\u2009\u2212\u200917.8), psychological health (\u03b2\u2009=\u2009\u2212\u200922.76), environmental health (\u03b2\u2009=\u2009\u2212\u200917.8), and social relationships (\u03b2\u2009=\u2009\u2212\u200922.12) than those who did not. A one-unit increase in the amount of social support, as a form of social interaction, led to a significant increase in physical health (\u03b2\u2009=\u20090.28), psychological health (\u03b2\u2009=\u20090.71), environmental health (\u03b2\u2009=\u20090.72), and social relationships (\u03b2\u2009=\u20090.70).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Adult Chinese patients with LOPD had a lower physical health and QOL compared to their counterparts with other RDs. Being employed was found to affect the QOL of adult Chinese patients with LOPD in almost all dimensions. Encouraging adult Chinese patients with LOPD to be socially active and help them become more involved in social life might improve their QOL.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13023-021-01836-y","type":"journal-article","created":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T12:01:23Z","timestamp":1620043283000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Quality of life and its contributors among adults with late-onset Pompe disease in China"],"prefix":"10.1186","volume":"16","author":[{"given":"Shanquan","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingxuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianfeng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger Yat-Nork","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9784-6472","authenticated-orcid":false,"given":"Dong","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,5,1]]},"reference":[{"key":"1836_CR1","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1007\/s10545-011-9320-x","volume":"34","author":"TA Kanters","year":"2011","unstructured":"Kanters TA, Hagemans MLC, van der Beek NAME, Rutten FFH, van der Ploeg AT, Hakkaart L. Burden of illness of Pompe disease in patients only receiving supportive care. J Inherit Metab Dis. 2011;34:1045\u201352. https:\/\/doi.org\/10.1007\/s10545-011-9320-x.","journal-title":"J Inherit Metab Dis"},{"issue":"751\u201376","key":"1836_CR2","doi-asserted-by":"publisher","first-page":"ix","DOI":"10.1016\/j.ncl.2014.04.010","volume":"32","author":"M Dasouki","year":"2014","unstructured":"Dasouki M, Jawdat O, Almadhoun O, Pasnoor M, McVey AL, Abuzinadah A, et al. Pompe disease: literature review and case series. Neurol Clin. 2014;32(751\u201376):ix. https:\/\/doi.org\/10.1016\/j.ncl.2014.04.010.","journal-title":"Neurol Clin"},{"key":"1836_CR3","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/s13023-018-0932-1","volume":"13","author":"K Szklanny","year":"2018","unstructured":"Szklanny K, Tylki-Szyma\u0144ska A. Follow-up analysis of voice quality in patients with late-onset Pompe disease. Orphanet J Rare Dis. 2018;13:189. https:\/\/doi.org\/10.1186\/s13023-018-0932-1.","journal-title":"Orphanet J Rare Dis"},{"key":"1836_CR4","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s12883-017-0983-2","volume":"17","author":"B Schoser","year":"2017","unstructured":"Schoser B, Bilder DA, Dimmock D, Gupta D, James ES, Prasad S. The humanistic burden of Pompe disease: are there still unmet needs? A systematic review. BMC Neurol. 2017;17:202. https:\/\/doi.org\/10.1186\/s12883-017-0983-2.","journal-title":"BMC Neurol"},{"key":"1836_CR5","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1097\/01.gim.0000218152.87434.f3","volume":"8","author":"PS Kishnani","year":"2006","unstructured":"Kishnani PS, Steiner RD, Bali D, Berger K, Byrne BJ, Case LE, et al. Pompe disease diagnosis and management guideline. Genet Med. 2006;8:267\u201388. https:\/\/doi.org\/10.1097\/01.gim.0000218152.87434.f3.","journal-title":"Genet Med"},{"key":"1836_CR6","doi-asserted-by":"publisher","first-page":"281","DOI":"10.21037\/atm.2019.05.47","volume":"7","author":"Y-H Chien","year":"2019","unstructured":"Chien Y-H, Hwu W-L, Lee N-C. Newborn screening: Taiwanese experience. Ann Transl Med. 2019;7:281. https:\/\/doi.org\/10.21037\/atm.2019.05.47.","journal-title":"Ann Transl Med"},{"key":"1836_CR7","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.clineuro.2010.09.016","volume":"113","author":"S Vielhaber","year":"2011","unstructured":"Vielhaber S, Brejova A, Debska-Vielhaber G, Kaufmann J, Feistner H, Schoenfeld MA, Awiszus F. 24-months results in two adults with Pompe disease on enzyme replacement therapy. Clin Neurol Neurosurg. 2011;113:350\u20137. https:\/\/doi.org\/10.1016\/j.clineuro.2010.09.016.","journal-title":"Clin Neurol Neurosurg"},{"key":"1836_CR8","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1212\/01.WNL.0000142597.69707.78","volume":"63","author":"MLC Hagemans","year":"2004","unstructured":"Hagemans MLC, Janssens ACJW, Winkel LPF, Sieradzan KA, Reuser AJJ, van Doorn PA, Van der Ploeg AT. Late-onset Pompe disease primarily affects quality of life in physical health domains. Neurology. 2004;63:1688\u201392. https:\/\/doi.org\/10.1212\/01.WNL.0000142597.69707.78.","journal-title":"Neurology"},{"key":"1836_CR9","doi-asserted-by":"publisher","first-page":"369.e27","DOI":"10.1111\/ene.12582","volume":"22","author":"M Boentert","year":"2015","unstructured":"Boentert M, Karabul N, Wenninger S, Stubbe-Dr\u00e4ger B, Mengel E, Schoser B, Young P. Sleep-related symptoms and sleep-disordered breathing in adult Pompe disease. Eur J Neurol. 2015;22:369.e27-376.e27. https:\/\/doi.org\/10.1111\/ene.12582.","journal-title":"Eur J Neurol"},{"key":"1836_CR10","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/0269215519876299","volume":"34","author":"J Dekker","year":"2020","unstructured":"Dekker J, de Groot V, ter Steeg AM, Vloothuis J, Holla J, Collette E, et al. Setting meaningful goals in rehabilitation: rationale and practical tool. Clin Rehabil. 2020;34:3\u201312. https:\/\/doi.org\/10.1177\/0269215519876299.","journal-title":"Clin Rehabil"},{"key":"1836_CR11","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s10545-015-9889-6","volume":"39","author":"D G\u00fcng\u00f6r","year":"2016","unstructured":"G\u00fcng\u00f6r D, Kruijshaar ME, Plug I, Rizopoulos D, Kanters TA, Wens SCA, et al. Quality of life and participation in daily life of adults with Pompe disease receiving enzyme replacement therapy: 10 years of international follow-up. J Inherit Metab Dis. 2016;39:253\u201360. https:\/\/doi.org\/10.1007\/s10545-015-9889-6.","journal-title":"J Inherit Metab Dis"},{"key":"1836_CR12","unstructured":"Yuan D. Expensive \u201corphan drugs\u201d: life-saving or Death-causing? Nanfang Weekend. August 24, 2017."},{"key":"1836_CR13","doi-asserted-by":"publisher","first-page":"5961","DOI":"10.3390\/ijerph17165961","volume":"17","author":"S Gong","year":"2020","unstructured":"Gong S, Li D, Dong D. How do patients and doctors perceive medical services for rare diseases differently in China? Insights from Two National Surveys. IJERPH. 2020;17:5961.","journal-title":"IJERPH"},{"key":"1836_CR14","doi-asserted-by":"publisher","first-page":"5444","DOI":"10.3390\/su12135444","volume":"12","author":"X Yan","year":"2020","unstructured":"Yan X, Dong D, He S, Webster C. Examining trans-provincial diagnosis of rare diseases in china: the importance of healthcare resource distribution and patient mobility. Sustainability. 2020;12:5444. https:\/\/doi.org\/10.3390\/su12135444.","journal-title":"Sustainability"},{"key":"1836_CR15","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.3390\/ijerph17051757","volume":"17","author":"X Yan","year":"2020","unstructured":"Yan X, He S, Dong D. Determining how far an adult rare disease patient needs to travel for a definitive diagnosis: a cross-sectional examination of the 2018 national rare disease survey in China. Int J Environ Res Public Health. 2020;17:1757. https:\/\/doi.org\/10.3390\/ijerph17051757.","journal-title":"Int J Environ Res Public Health"},{"key":"1836_CR16","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1086\/297748","volume":"60","author":"PS Visser","year":"1996","unstructured":"Visser PS, Krosnick JA, Marquette J, Curtin M. Mail surveys for election forecasting? An evaluation of the Columbus Dispatch poll. Public Opin Q. 1996;60:181\u2013227.","journal-title":"Public Opin Q"},{"key":"1836_CR17","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1093\/poq\/nfh006","volume":"68","author":"MD Kaplowitz","year":"2004","unstructured":"Kaplowitz MD, Hadlock TD, Levine R. A comparison of Web and mail survey response rates. Public Opin Q. 2004;68:94\u2013101. https:\/\/doi.org\/10.1093\/poq\/nfh006.","journal-title":"Public Opin Q"},{"key":"1836_CR18","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s13023-019-1054-0","volume":"14","author":"Y Zhao","year":"2019","unstructured":"Zhao Y, Wang Z, Lu J, Gu X, Huang Y, Qiu Z, et al. Characteristics of Pompe disease in China: a report from the Pompe registry. Orphanet J Rare Dis. 2019;14:78.","journal-title":"Orphanet J Rare Dis"},{"key":"1836_CR19","unstructured":"World Health Organization. Division of Mental Health. WHOQOL-BREF: introduction, administration, scoring and generic version of the assessment: field trial version, December 1996; 2012-06-16T23:32:37ZUR. https:\/\/apps.who.int\/iris\/handle\/10665\/63529."},{"key":"1836_CR20","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1023\/B:QURE.0000018486.91360.00","volume":"13","author":"SM Skevington","year":"2004","unstructured":"Skevington SM, Lotfy M, O\u2019Connell KA. The World Health Organization\u2019s WHOQOL-BREF quality of life assessment: psychometric properties and results of the international field trial. A report from the WHOQOL group. Qual Life Res. 2004;13:299\u2013310.","journal-title":"Qual Life Res"},{"key":"1836_CR21","doi-asserted-by":"publisher","DOI":"10.1017\/S1041610220001210","author":"D Burnette","year":"2020","unstructured":"Burnette D, Ye X, Cheng Z, Ruan H. Living alone, social cohesion, and quality of life among older adults in rural and urban China: a conditional process analysis. Int Psychogeriatr. 2020. https:\/\/doi.org\/10.1017\/S1041610220001210.","journal-title":"Int Psychogeriatr"},{"key":"1836_CR22","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12955-017-0628-6","volume":"15","author":"H Yu","year":"2017","unstructured":"Yu H, Li L, Liu C, Huang W, Zhou J, Fu W, et al. Factors associated with the quality of life of family caregivers for leukemia patients in China. Health Qual Life Outcomes. 2017;15:55.","journal-title":"Health Qual Life Outcomes"},{"key":"1836_CR23","doi-asserted-by":"publisher","first-page":"988","DOI":"10.4269\/ajtmh.19-0007","volume":"102","author":"G Li","year":"2020","unstructured":"Li G, Wang G, Hsu F-C, Xu J, Pei X, Zhao B, Shetty A. Effects of depression, anxiety, stigma, and disclosure on health-related quality of life among chronic hepatitis B patients in Dalian. China Am J Trop Med Hyg. 2020;102:988\u201394. https:\/\/doi.org\/10.4269\/ajtmh.19-0007.","journal-title":"China Am J Trop Med Hyg"},{"key":"1836_CR24","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s12955-020-01355-7","volume":"18","author":"B Bai","year":"2020","unstructured":"Bai B, Chen M, Fu L, Liu H, Jin L, Wei T, Xin F. Quality of life and influencing factors of patients with rheumatoid arthritis in Northeast China. Health Qual Life Outcomes. 2020;18:119.","journal-title":"Health Qual Life Outcomes"},{"key":"1836_CR25","doi-asserted-by":"publisher","first-page":"jrm00058","DOI":"10.2340\/16501977-2739","volume":"52","author":"F Chang","year":"2020","unstructured":"Chang F, Xie H, Zhang Q, Sun M, Yang Y, Chen G, et al. Quality of life of adults with chronic spinal cord injury in mainland china: a cross-sectional study. J Rehabil Med. 2020;52:jrm00058.","journal-title":"J Rehabil Med"},{"key":"1836_CR26","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1016\/S0140-6736(16)30418-4","volume":"387","author":"D Dong","year":"2016","unstructured":"Dong D, Wang Y. Challenges of rare diseases in China. The Lancet. 2016;387:1906. https:\/\/doi.org\/10.1016\/S0140-6736(16)30418-4.","journal-title":"The Lancet"},{"key":"1836_CR27","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1590\/S0034-8910.2014048004912","volume":"48","author":"PAB Silva","year":"2014","unstructured":"Silva PAB, Soares SM, Santos JFG, Silva LB. Cut-off point for WHOQOL-bref as a measure of quality of life of older adults. Rev Saude Publica. 2014;48:390\u20137. https:\/\/doi.org\/10.1590\/S0034-8910.2014048004912.","journal-title":"Rev Saude Publica"},{"key":"1836_CR28","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/1471-2288-12-37","volume":"12","author":"P Xia","year":"2012","unstructured":"Xia P, Li N, Hau K-T, Liu C, Lu Y. Quality of life of Chinese urban community residents: a psychometric study of the mainland Chinese version of the WHOQOL-BREF. BMC Med Res Methodol. 2012;12:37.","journal-title":"BMC Med Res Methodol"},{"key":"1836_CR29","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1161\/STROKEAHA.108.540054","volume":"40","author":"E Heeley","year":"2009","unstructured":"Heeley E, Anderson CS, Huang Y, Jan S, Li Y, Liu M, et al. Role of health insurance in averting economic hardship in families after acute stroke in China. Stroke. 2009;40:2149\u201356. https:\/\/doi.org\/10.1161\/STROKEAHA.108.540054.","journal-title":"Stroke"},{"key":"1836_CR30","first-page":"613","volume":"80","author":"MK Ranson","year":"2002","unstructured":"Ranson MK. Reduction of catastrophic health care expenditures by a community-based health insurance scheme in Gujarat, India: current experiences and challenges. Bull World Health Organ. 2002;80:613\u201321.","journal-title":"Bull World Health Organ"},{"key":"1836_CR31","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/j.socscimed.2005.07.001","volume":"62","author":"D McIntyre","year":"2006","unstructured":"McIntyre D, Thiede M, Dahlgren G, Whitehead M. What are the economic consequences for households of illness and of paying for health care in low- and middle-income country contexts? Soc Sci Med. 2006;62:858\u201365. https:\/\/doi.org\/10.1016\/j.socscimed.2005.07.001.","journal-title":"Soc Sci Med"},{"key":"1836_CR32","doi-asserted-by":"publisher","first-page":"600","DOI":"10.2471\/BLT.06.033720","volume":"85","author":"S Limwattananon","year":"2007","unstructured":"Limwattananon S, Tangcharoensathien V, Prakongsai P. Catastrophic and poverty impacts of health payments: results from national household surveys in Thailand. Bull World Health Organ. 2007;85:600\u20136. https:\/\/doi.org\/10.2471\/BLT.06.033720.","journal-title":"Bull World Health Organ"},{"key":"1836_CR33","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.healthpol.2009.08.006","volume":"94","author":"MS Yardim","year":"2010","unstructured":"Yardim MS, Cilingiroglu N, Yardim N. Catastrophic health expenditure and impoverishment in Turkey. Health Policy. 2010;94:26\u201333. https:\/\/doi.org\/10.1016\/j.healthpol.2009.08.006.","journal-title":"Health Policy"},{"key":"1836_CR34","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/S0140-6736(03)13861-5","volume":"362","author":"K Xu","year":"2003","unstructured":"Xu K, Evans DB, Kawabata K, Zeramdini R, Klavus J, Murray CJL. Household catastrophic health expenditure: a multicountry analysis. The Lancet. 2003;362:111\u20137. https:\/\/doi.org\/10.1016\/S0140-6736(03)13861-5.","journal-title":"The Lancet"},{"key":"1836_CR35","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1007\/s11136-012-0345-x","volume":"22","author":"W Wang","year":"2013","unstructured":"Wang W, Zheng X, He H-G, Thompson DR. Psychometric testing of the Chinese Mandarin version of the Medical Outcomes Study Social Support Survey in patients with coronary heart disease in mainland China. Qual Life Res. 2013;22:1965\u201371. https:\/\/doi.org\/10.1007\/s11136-012-0345-x.","journal-title":"Qual Life Res"},{"key":"1836_CR36","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/0277-9536(91)90150-B","volume":"32","author":"CD Sherbourne","year":"1991","unstructured":"Sherbourne CD, Stewart AL. The MOS social support survey. Soc Sci Med. 1991;32:705\u201314. https:\/\/doi.org\/10.1016\/0277-9536(91)90150-B.","journal-title":"Soc Sci Med"},{"key":"1836_CR37","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1002\/mus.21025","volume":"38","author":"JHJ Wokke","year":"2008","unstructured":"Wokke JHJ, Escolar DM, Pestronk A, Jaffe KM, Carter GT, Van Den Berg LH, et al. Clinical features of late-onset Pompe disease: a prospective cohort study. Muscle Nerve. 2008;38:1236\u201345. https:\/\/doi.org\/10.1002\/mus.21025.","journal-title":"Muscle Nerve"},{"key":"1836_CR38","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1056\/NEJMoa0909859","volume":"362","author":"AT Van der Ploeg","year":"2010","unstructured":"Van der Ploeg AT, Clemens PR, Corzo D, Escolar DM, Florence J, Groeneveld GJ, et al. A randomized study of alglucosidase alfa in late-onset Pompe\u2019s disease. N Engl J Med. 2010;362:1396\u2013406. https:\/\/doi.org\/10.1056\/NEJMoa0909859.","journal-title":"N Engl J Med"},{"key":"1836_CR39","doi-asserted-by":"publisher","first-page":"284","DOI":"10.21037\/atm.2019.07.24","volume":"7","author":"A Toscano","year":"2019","unstructured":"Toscano A, Rodolico C, Musumeci O. Multisystem late onset Pompe disease (LOPD): an update on clinical aspects. Ann Transl Med. 2019;7:284\u2013284.","journal-title":"Ann Transl Med"},{"key":"1836_CR40","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1111\/ene.13835","volume":"26","author":"O Musumeci","year":"2019","unstructured":"Musumeci O, Marino S, Granata F, Morabito R, Bonanno L, Brizzi T, Lo Buono V, Corallo F, Longo M, Toscano A. Central nervous system involvement in late-onset Pompe disease: clues from neuroimaging and neuropsychological analysis. Eur J Neurol. 2019;26:442.","journal-title":"Eur J Neurol"},{"key":"1836_CR41","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1002\/jimd.12272","volume":"43","author":"C Semplicini","year":"2020","unstructured":"Semplicini C, De Antonio M, Taouagh N, B\u00e9hin A, Bouhour F, Echaniz-Laguna A, Magot A, Nadaj-Pakleza A, Orlikowski D, Sacconi S, et al. Long-term benefit of enzyme replacement therapy with alglucosidase alfa in adults with Pompe disease: prospective analysis from the French Pompe Registry. J Inherit Metab Dis. 2020;43:1219\u201331.","journal-title":"J Inherit Metab Dis"},{"key":"1836_CR42","doi-asserted-by":"publisher","first-page":"3038","DOI":"10.1007\/s00415-020-09936-8","volume":"267","author":"DW Stockton","year":"2020","unstructured":"Stockton DW, Kishnani P, Van Der Ploeg A, Llerena J, Boentert M, Roberts M, Byrne BJ, Araujo R, Maruti SS, Thibault N, et al. Respiratory function during enzyme replacement therapy in late-onset Pompe disease: longitudinal course, prognostic factors, and the impact of time from diagnosis to treatment start. J Neurol. 2020;267:3038\u201353.","journal-title":"J Neurol"},{"key":"1836_CR43","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/1750-1172-8-49","volume":"8","author":"D G\u00fcng\u00f6r","year":"2013","unstructured":"G\u00fcng\u00f6r D, Kruijshaar ME, Plug I, D\u2019Agostino RB, Hagemans MLC, van Doorn PA, Reuser AJJ, van der Ploeg AT. Impact of enzyme replacement therapy on survival in adults with Pompe disease: results from a prospective international observational study. Orphanet J Rare Dis. 2013;8:49.","journal-title":"Orphanet J Rare Dis"},{"issue":"1023\u20131027","key":"1836_CR44","first-page":"e1021","volume":"158","author":"Y-H Chien","year":"2011","unstructured":"Chien Y-H, Lee N-C, Huang H-J, Thurberg BL, Tsai F-J, Hwu W-L. Later-onset Pompe disease: early detection and early treatment initiation enabled by newborn screening. J Pediatr. 2011;158(1023\u20131027):e1021.","journal-title":"J Pediatr"},{"key":"1836_CR45","doi-asserted-by":"crossref","unstructured":"Li C, Desai AK, Gupta P, Dempsey K, Bhambhani V, Hopkin RJ, Ficicioglu C, Tanpaiboon P, Craigen WJ, Rosenberg AS, Kishnani PS: Transforming the clinical outcome in CRIM-negative infantile Pompe disease identified via newborn screening: the benefits of early treatment with enzyme replacement therapy and immune tolerance induction. Genet Med. 2021.","DOI":"10.1016\/j.ymgme.2020.12.062"},{"issue":"2","key":"1836_CR46","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1002\/1520-6629(198304)11:2","volume":"11","author":"M Barrera Jr","year":"1983","unstructured":"Barrera M Jr, Ainlay SL. The structure of social support: a conceptual and empirical analysis. J Community Psychol. 1983;11(2):133\u201343. https:\/\/doi.org\/10.1002\/1520-6629(198304)11:2.","journal-title":"J Community Psychol"},{"issue":"2","key":"1836_CR47","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1080\/00909882.2017.1288292","volume":"45","author":"X Zhu","year":"2017","unstructured":"Zhu X, Smith RA, Parrott RL. Living with a rare health condition: the influence of a support community and public stigma on communication, stress, and available support. J Appl Commun Res. 2017;45(2):179\u201398. https:\/\/doi.org\/10.1080\/00909882.2017.1288292.","journal-title":"J Appl Commun Res"},{"key":"1836_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/13603116.2021.1888323","volume":"23","author":"EA Adama","year":"2021","unstructured":"Adama EA, Arabiat D, Foster MJ, Afrifa-Yamoah E, Runions K, Vithiatharan R, Lin A. The psychosocial impact of rare diseases among children and adolescents attending mainstream schools in Western Australia. Int J Incl Educ. 2021;23:1\u20134.","journal-title":"Int J Incl Educ"},{"key":"1836_CR49","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1097\/YCO.0b013e3282f3ad89","volume":"21","author":"M Reblin","year":"2008","unstructured":"Reblin M, Uchino BN. Social and emotional support and its implication for health. Curr Opin Psychiatry. 2008;21:201\u20135.","journal-title":"Curr Opin Psychiatry"},{"key":"1836_CR50","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s13023-017-0730-1","volume":"12","author":"KR Bogart","year":"2017","unstructured":"Bogart KR, Irvin VL. Health-related quality of life among adults with diverse rare disorders. Orphanet J Rare Dis. 2017;12:177. https:\/\/doi.org\/10.1186\/s13023-017-0730-1.","journal-title":"Orphanet J Rare Dis"},{"key":"1836_CR51","doi-asserted-by":"publisher","first-page":"A550","DOI":"10.1016\/j.jval.2017.08.859","volume":"20","author":"B Rupasinghe","year":"2017","unstructured":"Rupasinghe B, Gilbane A, Schlegel CR, Walsh K, Degun R. Launching combination therapies in rare diseases: is high cost burden restricting access? Value Health. 2017;20:A550. https:\/\/doi.org\/10.1016\/j.jval.2017.08.859.","journal-title":"Value Health"},{"key":"1836_CR52","doi-asserted-by":"publisher","first-page":"361","DOI":"10.5246\/jcps.2018.05.037","volume":"27","author":"F Mengyuan","year":"2018","unstructured":"Mengyuan F. Medical service utilisation, economic burden and health status of patients with rare diseases in China. J Chin Pharm Sci. 2018;27:361\u20139. https:\/\/doi.org\/10.5246\/jcps.2018.05.037.","journal-title":"J Chin Pharm Sci"},{"key":"1836_CR53","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/S0140-6736(12)60278-5","volume":"379","author":"Q Meng","year":"2012","unstructured":"Meng Q, Xu L, Zhang Y, Qian J, Cai M, Xin Y, et al. Trends in access to health services and financial protection in China between 2003 and 2011: a cross-sectional study. The Lancet. 2012;379:805\u201314. https:\/\/doi.org\/10.1016\/S0140-6736(12)60278-5.","journal-title":"The Lancet"},{"key":"1836_CR54","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-018-0198-8","author":"J Milverton","year":"2018","unstructured":"Milverton J, Newton S, Merlin T. The effectiveness of enzyme replacement therapy for juvenile-onset Pompe disease: a systematic review. J Inherit Metab Dis. 2018. https:\/\/doi.org\/10.1007\/s10545-018-0198-8.","journal-title":"J Inherit Metab Dis"},{"key":"1836_CR55","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.nmd.2008.04.009","volume":"18","author":"CI van Capelle","year":"2008","unstructured":"van Capelle CI, Winkel LPF, Hagemans MLC, Shapira SK, Arts WFM, van Doorn PA, et al. Eight years experience with enzyme replacement therapy in two children and one adult with Pompe disease. Neuromuscul Disord. 2008;18:447\u201352. https:\/\/doi.org\/10.1016\/j.nmd.2008.04.009.","journal-title":"Neuromuscul Disord"},{"issue":"4","key":"1836_CR56","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1007\/s00415-012-6636-x","volume":"260","author":"A Toscano","year":"2013","unstructured":"Toscano A, Schoser B. Enzyme replacement therapy in late-onset Pompe disease: a systematic literature review. J Neurol. 2013;260(4):951\u20139.","journal-title":"J Neurol"},{"key":"1836_CR57","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-018-0824-4","author":"JC van der Meijden","year":"2018","unstructured":"van der Meijden JC, Kruijshaar ME, Rizopoulos D, van Doorn PA, van der Beek NAME, van der Ploeg AT. Enzyme replacement therapy reduces the risk for wheelchair dependency in adult Pompe patients. Orphanet J Rare Dis. 2018. https:\/\/doi.org\/10.1186\/s13023-018-0824-4.","journal-title":"Orphanet J Rare Dis"},{"key":"1836_CR58","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3390\/rel1010018","volume":"1","author":"A B\u00fcssing","year":"2010","unstructured":"B\u00fcssing A, Koenig HG. Spiritual needs of patients with chronic diseases. Religions. 2010;1:18\u201327. https:\/\/doi.org\/10.3390\/rel1010018.","journal-title":"Religions"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-021-01836-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-021-01836-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-021-01836-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,20]],"date-time":"2021-07-20T20:04:24Z","timestamp":1626811464000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-021-01836-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,1]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1836"],"URL":"https:\/\/doi.org\/10.1186\/s13023-021-01836-y","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,1]]},"assertion":[{"value":"17 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Committee on the Use of Human and Animal Subjects in Teaching and Research, Hong Kong Baptist University (HASC no: FRG2\/15-16\/052). All participants provided informed consent before the survey was conducted.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"199"}}